Randomized Phase III Study Comparing the OSHO Arm to the Standard Intergroup Arm. Efficacy of Allogeneic Stem Cell Transplantation in Comparison to a Second Consolidation Chemotherapy in Elderly Patients With Newly Diagnosed AML in the Age Over 60 Years
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
comparison of event free survival (OSHO arm versus Standard intergroup arm)
after 5 years
Yes
Dietger Niederwieser, Prof.
Principal Investigator
University of Leipzig, Germany
Germany: Paul-Ehrlich-Institut
OSHO#069
NCT01497002
April 2005
December 2013
Name | Location |
---|